Natera, Inc. ( NTRA) - Key Metrics
NTRA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $5.25 | -$0.47 | $0.38 | -$0.06 |
| 2026Q1 | $4.92 | -$0.60 | $0.28 | $0.13 |
| 2025Q4 | $4.87 | $0.35 | $0.54 | $0.28 |
| 2025Q3 | $4.32 | -$0.64 | $0.43 | $0.18 |
| 2025Q2 | $4.01 | -$0.74 | $0.28 | $0.09 |
NTRA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -144.39 |
| 2026Q1 | 0% | -83.33 |
| 2025Q4 | 0% | 163.64 |
| 2025Q3 | 0% | -62.88 |
| 2025Q2 | 0% | -57.07 |
NTRA
Price: $400.71
52 week price:
Earnings Per Share: -1.31 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 659200
Ebitda: -23.3 millionMarket Capitalization: 57.4 billion